News Release

Eurofins MWG Operon and Genomatix launch strategic alliance

Exclusive worldwide cooperation in next-gen sequencing solutions provides full service for customers

Business Announcement

Genomatix Software GmbH

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

"We are pleased to cooperate with a partner offering such a high level of expertise in understanding and interpretation of complex biological processes. The special know-how of Genomatix with its rich proprietary data background will have an enormous impact on our service offerings to our customers and will add a further layer of quality to strengthen our position as the leading provider for next generation sequencing services" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.

Klaus May, Chief Business Officer of Genomatix, says: "Eurofins MWG Operon is an outstanding quality and service oriented company with friendly, bright and competent people. I am highly satisfied about this partnership, which represents the first one-stop-shop for complete project services, from experimental planning, wet-lab work and data analysis, to data interpretation and deep biological understanding. Together, we offer our customers cutting edge science and technology without the need for them to make major investments in equipment, infrastructure and manpower."

Both partners have already successfully worked together to gain several significant projects where applicative know-how and powerful bioinformatic capabilities have been key for effective project consulting and execution.

###

About Eurofins MWG Operon

Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in Europe, the United States, and Asia, is an international provider of DNA sequencing services, DNA synthesis products and bioinformatic services for academic and industrial research. As one of the first service providers for next generation sequencing, Eurofins MWG Operon has established profound know-how and proprietary protocols to cover a broad range of applications. The company's strength is its strong customer orientation, fast service, and high quality. For further information, please visit our website at: www.eurofinsdna.com

About Genomatix

Genomatix Software GmbH is a computational biology company headquartered in Munich, Germany with a seat of business in Ann Arbor, MI, U.S.A. Founded in 1997, Genomatix pioneered the analysis and understanding of eukaryotic gene regulation. More than a decade of developments in computational and systems biology has put Genomatix into the position to have a complete analysis pipeline in place at the arrival of next generation sequencing technology. Genomatix has published more than 180 peer reviewed scientific papers with more than 5,000 citations. Over 35,000 researchers worldwide currently apply Genomatix tools and databases. For further information, please visit www.genomatix.de

For further information please contact

Eurofins MWG Operon
Dr. Georg Gradl
Email: georggradl@eurofins.com
Phone: +49 8091 8289945

Genomatix
Dr. Martin Seifert
Email: seifert@genomatix.de
Phone: +49 89 599 766 0


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.